ETHEN 2ML Injection

ETHEN 2ML Injection is a potent antimalarial formulation containing Alpha Beta Arteether 150 mg, developed for the effective management of severe and complicated malaria. It is specifically intended for hospital use, where rapid control of parasitemia is critical to prevent disease progression and associated complications.In severe malaria cases, timely intervention plays a decisive role in patient outcomes. ETHEN 2ML is designed to act quickly and reliably, helping clinicians achieve early parasite clearance, clinical stabilization, and improved recovery rates. Its injectable form ensures immediate bioavailability, making it highly suitable for emergency and intensive care settings.

Mechanism of Action

Alpha Beta Arteether is a semi-synthetic derivative of artemisinin, a well-established class of antimalarial agents known for rapid parasite clearance.Once administered, ETHEN 2ML exerts its action by interacting with iron-rich components inside the malaria parasite. This interaction leads to the generation of highly reactive free radicals, which cause irreversible damage to essential parasite proteins and cellular membranes.This oxidative damage disrupts parasite metabolism and structural integrity, ultimately resulting in rapid death of the parasite (schizonticidal action). Due to its fast and potent activity, it is especially effective in reducing parasite load in Plasmodium falciparum infections, including resistant strains.

Indications

ETHEN 2ML Injection is indicated for the treatment of:

• Severe and complicated malaria requiring parenteral therapy
• Cerebral malaria with neurological involvement
• Multidrug-resistant malaria infections
• Plasmodium falciparum malaria
• Acute malaria cases where oral therapy is not feasible
• Hospitalized patients requiring rapid parasite control

Key Benefits

• Rapid and effective reduction of malaria parasite burden
• Early clinical improvement in critically ill patients
• Strong activity against drug-resistant malaria strains
• Reliable injectable option for emergency and ICU use
• Helps reduce the risk of complications associated with severe malaria
• Supports faster stabilization and recovery in acute cases
• Well-suited for hospital protocols requiring fast-acting antimalarial therapy

Dosage & Administration

ETHEN 2ML Injection is intended for intramuscular (IM) administration only and should be used strictly under medical supervision. The dosage regimen must be carefully determined by the treating physician based on the severity of the infection and the individual patient’s clinical condition. Generally, it is administered once daily as part of a short-course treatment plan for severe malaria. The injection should only be given by a qualified healthcare professional in a properly controlled clinical or hospital setting to ensure safe and effective use. Continuous clinical monitoring is recommended throughout the therapy to assess treatment response and patient improvement.

Why Choose ETHEN 2ML?

ETHEN 2ML is specially formulated to deliver fast, reliable, and clinically meaningful results in the management of severe malaria. It is developed keeping in view the critical nature and urgency of hospital-based malaria care, where timely intervention can significantly impact patient outcomes. The product contains a trusted arteether-based molecule with   well-established antimalarial efficacy, ensuring rapid parasite clearance even in complicated and resistant cases. It is ideally suited for emergency and intensive care settings where quick clinical response is essential. Manufactured under strict quality assurance standards, ETHEN 2ML ensures consistent performance along with safety and reliability. It also aligns well with modern treatment protocols for severe malaria management, offering healthcare professionals a dependable therapeutic option when every minute is crucial.